Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Isabel Lucena

Showing results (131-140 of 152) with videos related to

Pageof 16
Sort By:
Journal of Hepatology|June 25, 2021
Advanced preclinical models for evaluation of drug-induced liver injury - consensus statement by the European Drug-Induced Liver Injury Network [PRO-EURO-DILI-NET]Jose C Fernandez-Checa, Pierre Bagnaninchi, Hui Ye, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 12, 2021
Herbal and Dietary Supplements-Induced Liver Injury in Latin America: Experience From the LATINDILI NetworkFernando Bessone, Miren García-Cortés, Inmaculada Medina-Caliz, et al.
Pharmacogenetics and Genomics|September 13, 2012
Limited contribution of common genetic variants to risk for liver injury due to a variety of drugsThomas J Urban, Yufeng Shen, Andrew Stolz, et al.
Hepatology (Baltimore, Md.)|September 7, 2023
Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome: First report of the IAIHG retrospective registryCharlotte D Slooter, Floris F van den Brand, Ana Lleo, et al.
Plos One|March 21, 2017
A morphological method for ammonia detection in liverVirginia Gutiérrez-de-Juan, Sergio López de Davalillo, David Fernández-Ramos, et al.
Cell Death & Disease|February 11, 2022
Genetic and pharmacological inhibition of XBP1 protects against APAP hepatotoxicity through the activation of autophagyHui Ye, Chaobo Chen, Hanghang Wu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 9, 2018
Herbal and Dietary Supplement-Induced Liver Injuries in the Spanish DILI RegistryInmaculada Medina-Caliz, Miren Garcia-Cortes, Andres Gonzalez-Jimenez, et al.
Clinical Pharmacology and Therapeutics|May 9, 2019
Shared Genetic Risk Factors Across Carbamazepine-Induced Hypersensitivity ReactionsPaola Nicoletti, Sarah Barrett, Laurence McEvoy, et al.
Journal of Hepatology|February 4, 2021
Comprehensive analysis and insights gained from long-term experience of the Spanish DILI RegistryCamilla Stephens, Mercedes Robles-Diaz, Inmaculada Medina-Caliz, et al.
Revista Espanola De Cardiologia (English Ed.)|April 30, 2014
Use of drugs related to the treatment of diabetes mellitus and other cardiovascular risk factors in the Spanish population. The Di@bet.es studyGemma Rojo-Martínez, Sergio Valdés, Natalia Colomo, et al.
Pageof 16

Showing results (131-140 of 152) with videos related to

Sort By:
Pageof 16
Journal of Hepatology|June 25, 2021
Advanced preclinical models for evaluation of drug-induced liver injury - consensus statement by the European Drug-Induced Liver Injury Network [PRO-EURO-DILI-NET]Jose C Fernandez-Checa, Pierre Bagnaninchi, Hui Ye, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 12, 2021
Herbal and Dietary Supplements-Induced Liver Injury in Latin America: Experience From the LATINDILI NetworkFernando Bessone, Miren García-Cortés, Inmaculada Medina-Caliz, et al.
Pharmacogenetics and Genomics|September 13, 2012
Limited contribution of common genetic variants to risk for liver injury due to a variety of drugsThomas J Urban, Yufeng Shen, Andrew Stolz, et al.
Hepatology (Baltimore, Md.)|September 7, 2023
Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome: First report of the IAIHG retrospective registryCharlotte D Slooter, Floris F van den Brand, Ana Lleo, et al.
Plos One|March 21, 2017
A morphological method for ammonia detection in liverVirginia Gutiérrez-de-Juan, Sergio López de Davalillo, David Fernández-Ramos, et al.
Cell Death & Disease|February 11, 2022
Genetic and pharmacological inhibition of XBP1 protects against APAP hepatotoxicity through the activation of autophagyHui Ye, Chaobo Chen, Hanghang Wu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 9, 2018
Herbal and Dietary Supplement-Induced Liver Injuries in the Spanish DILI RegistryInmaculada Medina-Caliz, Miren Garcia-Cortes, Andres Gonzalez-Jimenez, et al.
Clinical Pharmacology and Therapeutics|May 9, 2019
Shared Genetic Risk Factors Across Carbamazepine-Induced Hypersensitivity ReactionsPaola Nicoletti, Sarah Barrett, Laurence McEvoy, et al.
Journal of Hepatology|February 4, 2021
Comprehensive analysis and insights gained from long-term experience of the Spanish DILI RegistryCamilla Stephens, Mercedes Robles-Diaz, Inmaculada Medina-Caliz, et al.
Revista Espanola De Cardiologia (English Ed.)|April 30, 2014
Use of drugs related to the treatment of diabetes mellitus and other cardiovascular risk factors in the Spanish population. The Di@bet.es studyGemma Rojo-Martínez, Sergio Valdés, Natalia Colomo, et al.
Pageof 16